Our services span the entire lifecycle of product development and commercialisation, and can be adapted to suit small local trials or large global programs.
Bringing the clinical trial to the patient with innovation and in-home solutions.
ICON provides its full range of clinical, consulting and commercial services across several industry sectors.
We have extensive experience in a broad range of therapeutic areas. Managing studies in all major geographies, we have established solid working relationships with the world’s leading investigators.
ICON has recently led the development of 17 vaccines resulting in FDA/EMA approvals. We are currently working on a number of COVID-19 vaccine trials.
With travel restrictions due to COVID-19, FIRECREST helps deliver and manage remote training for investigators.
BioPharma companies and Medical Devices manufacturers face growing operational, regulatory and economic challenges. ICON provides analysis and key insights on these challenges, with practical advice and recommendations.
Aggregated news on COVID-19 clinical trials.
Patient focused research for better outcomes.
ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.
Creating a world leader in healthcare intelligence and clinical research.
8 April, 2021
ICON is committed to making a positive impact on our people, environment and our community.
Partners making a difference.
Recognises ICON’s long-standing vaccine development expertise.
Global research network offering integrated solutions of patient assessments at site and in-home for decentralised trials